← All organizations
Highest phase reached
Phase 2
First clinical trial
Dec 1, 2012Last known activity
Jun 13, 2023
Timeline
1970s
- Jan 1, 1971
The Florey Institute of Neuroscience and Mental Health— Founded
Drugs by trial phase (7 distinct, 8 trials)
Phase 2 (6 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
- Alcohol Drinking
- Alcoholism
- Alzheimer Disease
- Cerebral Hemorrhage
- Cognition Disorders
- Cognitive Dysfunction
- Dementia
- Dementia, Vascular
- Disease
- Hemorrhage
- Ischemia
- Lewy Body Disease
- Neurocognitive Disorders
- Neurodegenerative Diseases
- Parasomnias
- Sleep Initiation and Maintenance Disorders
- Sleep Wake Disorders
- Stroke
- Tauopathies
Recent trials (11)
- NCT05959850Study chairPhase 2Jun 13, 2023
- NCT05959850OfficialPhase 2Jun 13, 2023
- NCT05959850Lead sponsorPhase 2Jun 13, 2023
- NCT04796636CollaboratorPhase 1Sep 27, 2021
- NCT03897062Lead sponsorPhase 2Apr 1, 2019
- NCT03538522CollaboratorPhase 2Sep 15, 2018
- NCT03385928Overall official - principal investigatorPhase 2Mar 19, 2018
- NCT03385928CollaboratorPhase 2Mar 19, 2018
- NCT03340493CollaboratorPhase 2Dec 6, 2017
- NCT02388061CollaboratorPhase 2Mar 1, 2015
- NCT01702636Overall official - principal investigatorPhase 2Dec 1, 2012
Details
- Founded
- Melbourne, AU Jan 1, 1971
- Last known activity
- Jun 13, 2023